The antibody is directed against rat CD53 and labels mature T and B cells but only 13% of thymocytes. OX-44 positive cells in the thymus include cells at all stages of differentiation to immunocompetent T cells.
| Institute |
|---|
| Medical Research Council; University of Oxford |
| Cat. #: | 156610 |
|---|---|
| Unit size: | 100 ug |
| Application: | FACS ; IHC ; IP |
| Target: | CD53 |
| Reactivity: | Rat |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | The antibody is directed against rat CD53 and labels mature T and B cells but only 13% of thymocytes. OX-44 positive cells in the thymus include cells at all stages of differentiation to immunocompetent T cells. |
|---|---|
| Conjugation: | Unconjugated |
| Immunogen: | T lymphocytes from a mixed lymphocyte reaction between purified rat T helper cells and irradiated semiallogeneic rat spleen |
| Myeloma used: | NS0/1 |
| Target background: | The antibody is directed against rat CD53 and labels mature T and B cells but only 13% of thymocytes. OX-44 positive cells in the thymus include cells at all stages of differentiation to immunocompetent T cells. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Bellacosa et al. 1991. Mol Cell Biol. 11(5):2864-72. PMID: 2017181. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151019 | Anti-Mos [S3.1] |
Key Info
Anti-Mos [S3.1]
|
View Tool | |||||||||||||||||||
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||||||
| 151033 | Anti-HSVUL42 [13C9] |
Key Info
Anti-HSVUL42 [13C9]
|
View Tool | |||||||||||||||||||
| 151034 | Anti-HSVUL42 [13D11] |
Key Info
Anti-HSVUL42 [13D11]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.